CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Kither Biotech Initiates Dosing of Patients in Phase 1b / 2a Study of KIT2014 in COPD

Phase 1KIT2014Positive
AI Analysis

Summary

Kither Biotech has initiated dosing of the first patients in a Phase 1b/2a clinical study of KIT2014 for moderate to severe COPD.

Clinical Trial Data

Phase

1b/2a

Importance:5/10
Sentiment:
0.50
clinical trialCOPDPhase 1b/2apatient dosing
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 29, 2026 7:30 AM

Read Original